Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1991
11/12/1991CA2041825A1 Renin inhibitors
11/12/1991CA2040530A1 Fluorinated derivatives of mevinic acids
11/12/1991CA1292049C Inclination measuring device
11/12/1991CA1292005C Biphenyl hydroxamic acids
11/12/1991CA1292003C Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers
11/12/1991CA1291999C Crystalline quinapril and a process for producing the same
11/11/1991WO1991016903A2 Use of purine derivatives for anesthesia, analgesia and in vivo organ preservation
11/10/1991WO1991017163A1 IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY
11/10/1991CA2080476A1 Azabenzimidazoles in the treatment of asthma, arthritis and related diseases
11/06/1991EP0455510A2 Use of 5-HT1A receptor agonist compounds for inhibiting gastric acid secretion
11/06/1991EP0455503A1 Composition for treating osteoporosis and hormonal imbalance
11/06/1991EP0455423A2 Ortho-lithiation process for the synthesis of 2-substituted 1-(tetrazol-5-yl) benzenes
11/06/1991EP0455422A2 Method of treating or preventing baldness with compositions containing fibroblast growth factor
11/06/1991EP0455271A2 Anti-inflammatory compositions
11/06/1991EP0455042A1 Combination of pravastatin and a fibric acid derivative, and method for treating dyslipidemia using such combination
11/06/1991EP0454736A1 Fibrinolysis by il-4
11/06/1991CN1055925A Pyridine derivatives
11/05/1991US5063234 Method of inhibiting demineralization of bone
11/05/1991US5063225 Benzothiazepines
11/05/1991US5062423 Equine aerosol drug delivery method and apparatus
11/05/1991CA2041799A1 Composition for treating osteoporosis and hormonal imbalance
11/05/1991CA2041742A1 Stabilization of somatotropins and other proteins by modification of cysteine residues
11/05/1991CA1291748C .beta.-LACTAM ANTIBIOTICS
11/05/1991CA1291710C Tetrapyrrole therapeutic agents
11/02/1991WO1991017149A1 3-naphthyl-3-carboxyalkylthio or oxy substituted alkanoic acid leukotriene antagonists
11/02/1991WO1991016889A1 Five-membered ring alkanoic acid leukotriene antagonists
11/02/1991CA2081480A1 3-naphthyl-3-carboxyalkylthio or oxy substituted alkanoic acid leukotriene antagonists
11/02/1991CA2081462A1 Five-membered ring alkanoic acid leukotriene antagonists
10/1991
10/31/1991WO1991016901A1 Oligonucleotide modulation of arachidonic acid metabolism
10/31/1991WO1991016437A1 Soluble peptide analogues containing binding sites
10/31/1991WO1991016355A1 Method for increasing blood-brain barrier permeability
10/31/1991WO1991016315A1 5-benzyl barbiturate derivatives
10/31/1991WO1991016310A1 Antimicrobial quinolone thioureas
10/31/1991WO1991016307A1 3-indolyl thioacetate derivatives
10/31/1991WO1991016303A1 Cyclic hydroxamic acids and their use
10/31/1991WO1991016302A1 Phenolic amine depigmenting and antimelanoma agents
10/31/1991WO1991016051A1 Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit egf receptor tyrosine kinase
10/31/1991WO1991016050A1 Veterinary treatment
10/31/1991WO1991013055A3 New aryl- and heteroarylethenylene derivatives and process for their preparation
10/31/1991CA2081769A1 Oligonucleotide modulation of arachidonic acid metabolism
10/31/1991CA2081308A1 Method for increasing blood-brain barrier permeability
10/31/1991CA2081207A1 Soluble peptide analogues containing binding sites
10/31/1991CA2080581A1 Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit egf receptor tyrosine kinase
10/31/1991CA2077435A1 Novel antimicrobial quinolone thioureas
10/31/1991CA2041454A1 Polypeptides
10/31/1991CA2039763A1 Combination of pravastatin and a fibric acid derivative, and method for treating dyslipidemia using such combination
10/30/1991EP0454511A1 N-substituted heterocycle derivatives, their preparation, compositions containing them
10/30/1991EP0454436A1 Pharmaceutical compounds
10/30/1991EP0454429A2 Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
10/30/1991EP0454044A2 Pharmacological product containing polyelectrolyte complexes in microparticulate form and at least one substance
10/30/1991EP0453960A1 Sulfonylamino substituted bicyclyl hydroxamic acid derivatives
10/30/1991EP0453515A1 Composition for treatment of senile dementia
10/30/1991EP0333740B1 Pharmaceutically active conjugates having improved body tissue binding specificity
10/30/1991CN1055739A Hemihydrate
10/30/1991CN1055735A Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
10/30/1991CN1055732A Novel alpha-mannosidase and fucosidase inhibitors
10/29/1991US5061802 17β-aminobenzoyl-4-aza-5α-androst-1-en-3-ones as benign prostatic hypertrophy agents
10/29/1991US5061801 Intermediate for making 3-oxo-4-aza-androst-1-ene 17β-ketones
10/29/1991US5061734 Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis
10/29/1991US5061730 Inhibitors of dehydropeptidase and renal dipeptidase; prevent unnecessary hydrolysis of beta-lactam ring of carbapenem antib iotics
10/29/1991US5061721 Side effect reduction
10/29/1991US5061718 Benzothiazolylmethoxy compounds, pharmaceutical compositions comprising the same and their use as anti-inflammatory or anti-allergenic agents
10/29/1991US5061710 Mercapto-acylamino acid antihypertensives
10/29/1991US5061704 Pathologies involving loss of bone tissue
10/29/1991US5061694 Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
10/29/1991CA1291479C Piperazihyl-l-pyrimidine derivatives, their preparation and their application in drugs and cosmetics
10/28/1991WO1991017161A1 Isoquinoline amides and esters as 5 ht3 receptor antagonists
10/28/1991WO1991000092A1 Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages
10/28/1991CA2081350A1 Isoquinoline amides and esters as 5 ht3 receptor antagonists
10/28/1991CA2042014A1 Method of treating or preventing baldness with compositions containing fibroblast growth factor
10/27/1991WO1991016058A1 Composition and method for topical treatment of damaged or diseased tissue
10/27/1991CA2081340A1 Composition and method for topical treatment of damaged or diseased tissue
10/24/1991WO1991016888A1 Spiro[benzofurancycloalkane]carboxamides as 5ht3 antagonists
10/24/1991CA2081011A1 Spiro[benzofurancycloalkane]carboxamides as 5ht3 antagonists
10/23/1991EP0453210A2 Pyridine derivatives
10/23/1991EP0453195A1 (S)-alkyl 3-(thien-2-ylthio) butyrate and analogs and synthesis thereof
10/23/1991EP0453097A2 Zusammensetzung enthaltend zumindest zwei verschiedene Antikörper oder deren Fragmente
10/23/1991EP0452908A2 Lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids
10/23/1991EP0452587A1 Dihydroxy sulfonamide and sulfinamide renin inhibitors
10/23/1991EP0452364A1 Method for preparing water soluble polypeptides
10/23/1991EP0418230A4 Method for potentiating and inhibiting insulin-like growth factor activity
10/23/1991EP0291507B1 Electronic inclinometer
10/22/1991US5059712 Isolating aminoarginine and use to block nitric oxide formation in body
10/22/1991US5059627 For mammals suffering from degenerative nervous system disorders
10/22/1991US5059613 Topically active ocular benzothiazole sulfonamide carbonic anhydrase inhibitors
10/22/1991US5059610 Treatment of hypersensitive disorders; antiinflammatory, antiallergic agents
10/22/1991US5059592 Composition for prevention and (or) treatment of AIDS
10/22/1991US5059588 Methods and compositions for healing bone using gly his lys: copper
10/22/1991CA1291143C Hmg-coa reductase inhibitors
10/22/1991CA1291131C 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8,-inter- m-phenylene pgi _derivatives
10/21/1991WO1991016298A1 Antiinflammatory hydroxamic acids and n-hydroxyureas
10/21/1991CA2078216A1 Antiinflammatory hydroxamic acids and n-hydroxyureas
10/20/1991CA2040747A1 Pyridine derivatives
10/20/1991CA2040608A1 Lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids
10/19/1991CA2040605A1 (s)-alkyl 3-(thien-2-ylthio)butyrate and analogs and synthesis thereof
10/17/1991WO1991016305A1 Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase
10/17/1991WO1991015770A1 Therapeutic uses of actin-binding compounds
10/17/1991WO1991015513A1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides
10/17/1991WO1991015475A1 Novel vitamin d analogues
10/17/1991WO1991015468A1 Novel compound
1 ... 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 ... 1564